Factors related to patient adherence to antidiabetic drug therapy by Gimenes, Heloisa Turcatto et al.
46
FACTORS RELATED TO PATIENT ADHERENCE TO ANTIDIABETIC DRUG THERAPY1
Heloisa Turcatto Gimenes2
Maria Lúcia Zanetti3
Vanderlei José Haas4
Gimenes HT, Zanetti ML, Haas VJ. Factors related to patient adherence to antidiabetic drug therapy. Rev Latino-
am Enfermagem 2009 janeiro-fevereiro; 17(1):46-51.
The objective of the present study was to assess patient adherence to antidiabetic drug therapy and its association
with factors related to the patient, patient-provider relationship, therapeutic regimen and the disease itself. The
study comprised 46 diabetic patients enrolled in a research and extension education center in the State of Sao
Paulo, southeastern Brazil, in 2007. Data was collected through interviews using a questionnaire and the
Treatment Adherence Measure (TAM). The patient adherence level to antidiabetic drug therapy was 78.3%. In
conclusion, since prevalence of adherence is below that recommended in the literature, and in the light of poor
blood glucose control and alleged failure of therapeutic regimen, health providers are urged to measure diabetic
patient treatment adherence, because it is key to adequate diabetes management with drugs.
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FACTORES RELACIONADOS A LA ADHESIÓN DEL PACIENTE DIABÉTICO A LA
TERAPÉUTICA MEDICAMENTOSA
Este estudio tuvo el objetivo de determinar la adhesión del paciente diabético a la terapéutica medicamentosa
y verificar la asociación de la adhesión con factores relacionados al paciente, a la relación profesional-paciente,
al esquema terapéutico y a la enfermedad. Participaron 46 diabéticos registrados en un centro de investigación
y extensión universitaria en el interior del Estado de San Pablo, en 2007. Los datos fueron obtenidos mediante
entrevista, utilizándose un cuestionario y la prueba de Medida de Adhesión al Tratamiento – MAT. Los resultados
mostraron que la adhesión del paciente diabético al tratamiento medicamentoso para tratamiento de la diabetes
fue de 78,3%. Se concluye que, al considerar que la prevalencia de la adhesión obtenida en el presente estudio
estuvo por debajo de la recomendada en la literatura y frente a la vigencia del mal control de la glucemia y de
la supuesta falencia en el esquema terapéutico, se urgente que los profesionales de la salud reconozcan la
importancia de evaluar la adhesión de los pacientes diabéticos, al tratamiento medicamentoso para controlar
la diabetes.
DESCRIPTORES: enfermería; diabetes mellitus; aceptación de la atención de salud
FATORES RELACIONADOS À ADESÃO DO PACIENTE DIABÉTICO À
 TERAPÊUTICA MEDICAMENTOSA
Este estudo teve o objetivo de determinar a adesão do paciente diabético à terapêutica medicamentosa e
verificar a associação da adesão, segundo os fatores referentes ao paciente, ao relacionamento profissional-
paciente, ao esquema terapêutico e à doença. Participaram 46 diabéticos cadastrados em um centro de pesquisa
e extensão universitária no interior do Estado de São Paulo, em 2007. Os dados foram obtidos mediante
entrevista, utilizando-se questionário e o teste de Medida de Adesão ao Tratamento – MAT. Os resultados
mostraram que a adesão do paciente diabético ao tratamento medicamentoso para o diabetes foi de 78,3%.
Conclui-se que, ao se considerar que a prevalência da adesão obtida no presente estudo está abaixo daquela
recomendada na literatura, se torna urgente reconhecer a importância da mensuração da adesão dos pacientes
diabéticos em tratamento medicamentoso, para o controle do diabetes pelos profissionais de saúde, na vigência
de mau controle glicêmico e de suposta falência no esquema terapêutico.
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BACKGROUND
It has been shown in clinical practice that
patients have difficulty in taking the prescribed
medications, following a diet and changing their
lifestyle as directed by a multidisciplinary team. It
is estimated that only a third of patients have
adequate treatment adherence(1).
Several studies investigating adherence to
chronic disease treatment have evidenced that
patients often discontinue their medications or
even do not take them at all because they consider
them ineffective or experience untoward side
effects(2-4). Among diabetes patients, many believe
they do not need any drug therapies as they have
no symptoms.
Different definitions of adherence have
been proposed but it is generally defined as no
less than 80% use of prescribed drugs and other
procedures, as well as compliance with doses,
times, and treatment duration. It represents the
final step of a proposed rational drug use(3,5).
Many factors can affect treatment
adherence and there is no consensus on which has
the greatest impact. First, it should be considered
whether patients have access to drugs. Ruling out
the possibility of no access, patient adherence to
drug therapy can be divided into four groups of
factors: patient-related; related to patient-provider
relationship, therapeutic regimen, and the disease
itself(1,3).
A complex variety of determinants clearly
plays a role in patient adherence to the therapeutic
regimen and contributes to non-adherence of those
with chronic conditions like diabetes.
There is a lack of studies investigating
adherence to antidiabetic drug therapy, and those
available have different designs and inconsistent
results. Further investigation is needed as most
studies have focused on patient adherence to anti-
hypertensive and lipid-reducing drugs instead of
to oral antidiabetic agents and insulin(4,6-7).
Researchers and health providers have
recently been devoting a great deal of effort to
better understand non-adherence to drug therapy.
It is though a challenge as people’s behaviors
involve complex mechanisms. There is a need to
further explore this issue in order to identify
behaviors that facilitate and/or prevent adherence
to drug therapy.
OBJECTIVE
To assess patient adherence to antidiabetic
drug therapy and to describe its association to
factors related to the patient, patient-provider
relationship, therapeutic regimen, and the disease
itself.
MATERIALS AND METHODS
Cross-sect ional,  descr ipt ive study
conducted as part of the Diabetes Education
Program in a research and extension center in a
city in the state of São Paulo, southeastern Brazil,
in 2007. The study comprised 46 patients with
median age 57; 69.6% of them were females and
78.3% were married; median schooling was eight
years; and family income was 4.5 monthly
minimum wages (MMWs). The majority had type 2
diabetes (82.6%), and median time from diagnosis
was 12.5 years. Median glycated hemoglobin
(HbA1) level measured before data collection was
8.5. Their main comorbidit ies were: arter ia l
hypertension (56.5%), dyslipidemia (43.5%), and
obesity (41.3%). As for drug therapy for diabetes
management, 58.7% were taking oral antidiabetic
agents; 30.4% oral antidiabetic agents plus insulin;
and 10.9% insulin.
Data was collected using a questionnaire
addressing patient information (gender, age,
schooling, and family income), patient-provider
relationship (information on disease and drugs and
patient involvement in therapy choice), therapeutic
regimen (changes in daily life, side effects and use
of anti-hypertensive agents) and the disease
(diabetes duration, HbA1 levels, patient knowledge
on diabetes and i ts management) and the
Treatment Adherence Measure (TAM). The TAM
instrument consists of seven i tems and was
developed and validated in Portugal with good
internal consistency (p<0.001). It also showed good
concurrent validity with high correlations in any
answer and 0.77 sensitivity and 0.73 specificity,
proving to be a good instrument for capturing a
variety of behaviors involved in treatment
adherence(8).
A literature search did not find any studies
on the applicability of TAM instrument in Brazilian
subjects. But given the closeness between European
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– the instrument’s original language – and Brazilian
Portuguese and the fact that different cultural
backgrounds do not have an effect on the
instrument items, it was first translated from
European into Brazilian Portuguese. It was then
reviewed by three diabetes specialists and checked
for item intelligibility, easy reading comprehension
and presentation format, which were deemed
adequate for the purposes of the study. A pilot
study was carried out with five patients at the study
site and the instrument proved to be adequate for
administration in the study.
After subjects’ consent, data were collected
at the study site through guided interviews that
lasted on average 30 minutes. Patients were
addressed upon their arrival at the center and
individually interviewed in a private room by a
single interviewer. Medical records as well as
diabetes test results of all subjects were reviewed.
The analysis of TAM items was based on
answers rated on a Likert-type scale for each
question (always (1); almost always (2); frequently
(3); sometimes (4); rarely (5); and never (6)).
Scores for each TAM question were added up and
divided by the total number of questions and then
dichotomized as adherent or non-adherent to drug
therapy. Univariate and bivariate analyses were
conducted using absolute and relative frequencies
and 2x2 contingency tables. Fisher’s exact test was
performed to assess the association between
adherence and factors related to the patient,
patient-provider relationship, therapeutic regimen,
and the disease itself. It was opted for this test
because of the small sample size and the expected
result frequency (lower than five in all associations
studied). A 5% significance level was set. The study
was approved by the Research Ethics Committee
at the University of São Paulo at Ribeirão Preto
College of Nursing (Protocol No. 0541/2005).
RESULTS
Of 46 (100%) subjects studied, 78.3%
were adherent and 21.7% were non-adherent to
drug therapy. Table 1 shows the prevalence of
patient adherence to drug therapy according to
factors related to the patient, patient-provider
re la t i onsh ip ,  therapeut i c  reg imen,  and  the
disease itself.
Table 1 – Prevalence of adherence to antidiabetic drug
therapy according to factors related to the patient,
patient-provider relationship, therapeutic regimen,
and the disease itself. Ribeirão Preto, Brazil, 2007
1Variables were dichotomized for Fisher’s exact test;
2 “Do not know” and “Unknown” answers were considered missing information
to perform Fisher’s exact test
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The analysis of patient-related factors showed
higher prevalence of adherence among men (85.7%),
the elderly (82.4%), those with more than 12 years of
schooling (88.9%) and family income greater than five
MMWs (90%).
As for factors related to the patient-provider
relationship, those who received information about the
disease and specific information about the drug
prescribed (84.6 and 86.7%, respectively) were more
adherent to antidiabetic drug therapy. As for patient
involvement in drug therapy choice, prevalence of
adherence was similar in patients who were asked their
opinion and those who were not.
In regard to factors related to the therapeutic
regimen, of 46 (100%) subjects studied, 80.4% did not
report any changes in their daily life while 19.6% did
report them. Of these subjects reporting changes, 8.7%
said they made drug use more difficult. The prevalence
of adherence was higher (81.1%) in those who did not
report any changes. Drug side effects were reported in
65.2% of subjects and prevalence of adherence was
70% among them. Those who did not report any side
effects had 93.8% prevalence of adherence.
With respect to factors related to the disease
itself, of 80.4% who had HbA1 results available, the
prevalence of adherence was 66.7% among those with
HbA1 above 7% and 33.3% among those with HbA1
lower than 7%. It should be noted that prevalence of
non-adherence in those with HbA1 greater than 7% was
85.7%.
As for diabetes duration, prevalence of
adherence in subjects with five years or less of diagnosis
was 80%, against 77.4% in those with more than five
years. As for patient knowledge on diabetes
management, the prevalence of adherence was 87%
in those who reported poor glucose control and 68.2%
in those who reported good control. The prevalence of
adherence in those subjects who had knowledge on the
prescribed drug was 72.7%, against 80.8% among those
with limited knowledge.
Although different prevalences of adherence
were found for each factor studied, these differences
were not statistically significant (p>0.05) in Fisher’s exact
test, as shown in Table 1.
DISCUSSION
The prevalence of patient adherence to drug
therapy for diabetes management found in the study
was 78.3%. It is similar to that described in diabetes
patients receiving drug therapy, 79.7%(9). Another
study showed 95.7% prevalence of adherence to
antihyperglycemic agents in type 2 diabetic
patients(4).
As for patient-related factors associated to
adherence to drug therapy, higher adherence among
men than women could be explained by the fact that
women are more prone to stress and to develop
mental health conditions. Thus, emotional disorders
like depression can be associated with non-adherence
to drug therapy(10).
Data on age is consistent with the literature;
chronic patients’ age affects adherence to drug
therapy, as lower adherence was seen among
younger patients(11).
In regard to schooling, more educated
patients were more adherent to therapy. Low schooling
makes learning more difficult; as diabetes drug
therapy gets more complex, patients are required to
have more complex cognitive skills to be able to
understand the prescribed drug therapy and to adhere
to treatment for good glucose control.
As for family income, the study data
corroborates the findings of another study that
reported that those with family income less than five
MMWs showed lower adherence when compared to
those with higher income(9).
As for factors related to the patient-provider
relationship, the present study showed that patients’
knowledge on diabetes and the proposed treatment
directly influences their adherence to drug therapy.
Patients’ perception of the expected treatment benefits
increases their adherence. However, it was verified
that health providers rarely assess patient knowledge
as part of their clinical routine(7).
Treatment adherence is a complex
phenomenon influenced by multiple determinants. The
patients’ beliefs on drugs may be the key for their
adherence to drug therapy, as they often choose to
take a drug or not based on information they have
about them.
A study reported that 82% of the diabetic
patients studied believed the prescribed drugs would
relieve their symptoms and 83% believed they would
protect their health in the future. These subjects had
higher adherence rates to drug therapy than those
who distrusted it (98.5 and 87%, respectively)(4).
It is crucial that patients are actively involved
in drug therapy choice. When patients are involved
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at the moment health providers propose a therapeutic
plan, they feel more motivated and their positive
beliefs overcome their concerns about the drug
prescribed, resulting in greater adherence to the
proposed therapy(11).
In regard to factors related to the
therapeutic regimen, drug therapy adherence was
more prevalent among those subjects who reported
changes in their daily life as well in those who did
not have side effects.
Depending on the type of drug prescribed,
diabetic patients have to make changes in their daily
life. The administration of certain drugs, such as
insulin, requires patients to make adjustments in
their daily habits, especially regarding meal times
and physical activity.
As for drug side effects, they are quite often
attributed to non-adherence to drug therapy.
However, patients are seldom asked about them
during multiprofessional team care.
A study of type 2 diabetic patients reported
that, for the majority (58%), side effects were a
main factor limiting adherence. Only 23% of them
reported these effects to their doctors and 83%
experienced them for more than a month(4). Side
effects can thus become chronic and patients may
experience them for long periods of time, which can
affect their adherence to drug therapy.
While prescribing drugs for diabetes
management, prescribers should inform their
patients on potential side effects that may occur in
the beginning or throughout therapy. In every follow-
up visit, providers should ask their patients about
any side effects and how they are affecting drug
use and make adjustments to the therapeutic
regimen as needed. When providers show concern
about pat ient wel l -being,  pat ients are more
likely to attend the visits and have an adequate
follow-up(5,7).
Patients should be asked about any
problems affecting adherence due to the complexity
of drug therapy. Doctors may offer patients less
complex therapies, adjusted to the patient’s needs,
to help them better comply with the therapeutic
regimen(7).
In regard to disease-related factors, the
literature shows a significant association between
changes in HbA1 levels and patient adherence to
drug therapy for diabetes management. For each
10% improvement in adherence to oral antidiabetic
agents, HbA1 levels were reduced by about 0.19%
(p<0.0001)(9).
It is thus suggested that, in patients with
abnormal HbA1 levels, rather than increasing the
prescribed dose, adding a different drug or even
replacing the prescribed drug, health providers
should first assess patient adherence to drug
therapy(12).
More aggressive, earlier intervention in
diabetes treatment has been recommended with a
view to glucose management. This recommendation
is supported by the fact that, in the United States,
the proportion of type 2 diabetic patients with HbA1
levels below 7% has dropped 20% in recent years.
The Brazilian scenario is quite similar. It stresses
patient non-adherence to the prescribed drug
therapy(13) as a probable cause.
Another important aspect that affects
disease-related adherence to drug therapy is
diagnosis duration. The present study findings are
consistent with those reported by the World Health
Organization (WHO), pointing out a negative
relationship between diabetes duration and patient
adherence to drug therapy. Those patients with
longer disease duration tend to be less adherent to
treatment(14).
Lower adherence rates to drug therapy for
diabetes management is a matter of concern as
disease progresses because diabetes is a
progressive silent disease, and chronic complications
due to poor glucose control are likely to increase
with time.
As for patient knowledge on diabetes
management, the study showed higher rates of
adherence among those reporting poor glucose
management. This is an important finding because
it highlights the fact that patients with good
metabolic control seem less concerned about
disease management and have lower adherence
rates. With respect to patient knowledge on diabetes
drugs, adherence was higher among those subjects
with limited knowledge.
Despite all recommendations and protocols,
since patients are not properly advised on the use
of oral antidiabetic agents, their use is inadequate,
result ing in poor glucose control (13). Limited
knowledge on drug therapy has proven to have
great impact on patients’ health and quality of life,
especial ly in those with one or more chronic
conditions. Hospital admissions and premature
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deaths have increased and been associated to
limited knowledge(15).
When accurate and clear information on
diabetes drugs is provided, patients are encouraged
towards self-care and adherence to drug therapy. A
joint approach of health providers and patients can
help narrowing patients’ knowledge gap.
Although different prevalence rates of
adherence were found for all factors in the present
study, these differences were not statistically
significant. This could be explained by the small
size of the convenience sample, which included
patients attending a health service with the purpose
of improving their knowledge on diabetes. It is thus
a di f ferent iated sample, because pat ients
supposedly sought diabetes education to better
understand their disease and drug therapy and,
thus, increase adherence to the prescr ibed
therapy. In the light of the factors discussed here,
efforts should be made to improve diabetic patient
adherence to drug therapy and, consequently,
diabetes management.
CONCLUSIONS
The present study found 78.3% patient
adherence to antidiabetic drug therapy. Although
different prevalences of adherence were seen for
each factor studied, the associat ion was not
statistically significant. It can be concluded that,
since the prevalence of adherence found in the
present study is below that recommended in the
literature, it is crucial that health providers assess
adherence of patients to drug therapy in the event
of poor glucose control and presumed failure of
the prescribed therapeutic regimen.
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